Neurology

What is Neurology?

Neurology is a branch of medical science that is concerned with disorders and diseases of the nervous system. The term neurology comes from a combination of two words - "neuron" meaning nerve and "logia" meaning "the study of".

Neurological Infections

Neurogenesis

Electroencephalogram (EEG) Systems Explained

Neurogenetics: Genetics and Neurology

What are Neuronal Markers?

What is Neuronal Plasticity and Why Is It Important?

Signals from Gut Biome to Brain and Behavior

What is Neurosurgery?

How are 'Strong' Memories Formed?

Using Antibodies for Parkinson's Disease Research

What are Glutamate Receptors?

See more featured articles »

What is Neurooncology?

What are Neuroepithelial Cells?

What is Pediatric Neurology?

Lab-Grown Neurons

What is Neurotoxicity?

What is Neuroscience?

What are Mirror Neurons?

What is the Difference Between Neurology and Neuroscience?

What are Neurotransmitters?

What are Glial Cells?

Latest Neurology News and Research

New brain atlas reveals insights into Huntington's, addiction, and other disorders

A region of the brain called the striatum is critical for many cognitive and motor functions, including decision-making, control of movement, habit formation, and processing of reward.

1 Sep 2026

AAN launches new resource to help people find reliable information about brain health

The American Academy of Neurology (AAN) has launched BrainHealth.com, a new public resource offering expert-reviewed information, tools and stories to help people improve and protect their brain health.

1 Sep 2026

Targeted MS treatment protects the overall immune system

UZH researchers have developed a novel therapy for multiple sclerosis that is designed to stop the misguided immune response without suppressing the immune system as a whole.

1 Sep 2026

New guideline updates medications for preventing migraine in adults

To help clinicians determine which medications may be most effective at preventing migraine in adults, the American Academy of Neurology (AAN) and American Headache Society (AHS) have issued a joint practice guideline update with evidence-based recommendations, published on August 31, 2026, in Neurology®, the medical journal of the American Academy of Neurology, and in Headache, the official journal of the American Headache Society.

31 Aug 2026

New stroke guidelines could help pave the way for precision rehabilitation

A University of Maryland School of Medicine (UMSOM) stroke rehabilitation specialist helped develop new recommendations for studying molecular biomarkers associated with recovery from stroke.

28 Aug 2026

UCSF scientists build largest molecular interaction map for autism

For more than two decades, researchers have identified hundreds of genes that increase the risk of autism spectrum disorder (ASD).

28 Aug 2026

Parkinson’s disease imposes €22.8 billion economic burden across Europe

The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, a new study published today in Movement Disorders has shown.

27 Aug 2026

Post-seizure psychotic episodes linked to future mental health risks

Some people with epilepsy experience delusions, hallucinations, paranoia and confusion after a seizure.

27 Aug 2026

Brain shrinkage biomarker may predict early-onset Alzheimer’s progression

In people diagnosed with early-onset Alzheimer's disease, a biomarker tool that detects shrinkage of the brain's gray matter may predict how quickly someone may progress from mild cognitive impairment (MCI) to dementia, according to a new study published August 26, 2026, in Neurology, an official journal of the American Academy of Neurology.

27 Aug 2026

Brain atrophy on MRI could help predict Alzheimer’s progression

Mass General Brigham Neuroscience Institute researchers have found that a pattern of brain atrophy visible on MRI could help predict how quickly people with early-onset Alzheimer's disease progress from mild cognitive impairment to dementia.

27 Aug 2026

FDA endorses alpha-synuclein biomarker for Parkinson’s clinical trials

Critical Path Institute® (C-Path) today announced the publication of "Regulatory endorsement for the application of alpha-synuclein seed amplification assay (αSyn-SAA) as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies" in the Journal of Parkinson's Disease, marking a significant milestone for its Critical Path for Parkinson's consortium.

25 Aug 2026

Study reveals how the brain balances competing goals

How do we decide what to do when faced with choices? And how does the brain adapt those decisions as the world around us changes? A new study published in Nature by researchers at Baylor College of Medicine and Duncan Neurological Research Institute at Texas Children's Hospital offers surprising insights by revealing how the human brain continuously balances competing goals in real time.

25 Aug 2026

Researchers find alarming rates of CTE in former football players

In a new study from Mass General Brigham, Boston University (BU), and the Concussion & CTE Foundation, researchers found evidence that at least 1-in-4 former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy (CTE) at the time of their death, a much higher prevalence compared to the general population.

25 Aug 2026

Novel blood-based method diagnoses Alzheimer’s disease with high accuracy

Alzheimer's disease (AD) accounts for 60–80% of global dementia cases, with its core pathological feature being the misfolding and aggregation of β-amyloid (Aβ) proteins in the brain.

25 Aug 2026

Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players

At minimum, nearly a quarter of all former National Football League (NFL) players who died from 2016 to 2021 had confirmed chronic traumatic encephalopathy (CTE) – a neurodegenerative disease linked to repeated head impacts – at death, finds a study published by The BMJ today.

25 Aug 2026

Shared protein pathology redefines treatment for multiple neurodegenerative diseases

On the surface, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE) might seem like unrelated diseases.

24 Aug 2026

Short workouts or naps protect memory after sleep deprivation

A short workout or a nap can help protect memory after a sleepless night, a McGill University-led study has found.

24 Aug 2026

FDA clears innovative blood test for earlier Alzheimer's diagnosis

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer's disease.

21 Aug 2026

Only three of 1,357 FDA-cleared AI devices tested patient outcomes

Researchers found that among 1,357 FDA-cleared or approved AI/ML-enabled medical devices, only 34 were linked to registered clinical trials and just three had been evaluated for patient-centered outcomes. The study highlights major gaps in prospective testing, demographic representation, transparency, and evidence showing whether medical AI meaningfully improves patients’ health.

20 Aug 2026

Two distinct types of brain tissue work together to support cognition in older adults

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have found that two distinct types of brain tissue work together to support cognition in older adults, and that the health of the brain's short-range wiring may help soften the cognitive effects of gray matter loss.

20 Aug 2026